Influence of myocardial fibrosis and blood oxygenation on heart t2*values in thalassemia patients

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 4, 2009, Pages 832-837

  Meloni, Antonella ^a   Pepe, Alessia ^a   Positano, Vincenzo ^a   Favilli, Brunella ^a   Maggio, Aurelio ^b   Capra, Marcello ^c   Pinto, Carmela Lo ^d   Gerardi, Calogera ^e   Santarelli, Maria Filomena ^a   Midiri, Massimo ^f   Landini, Luigi ^a,g   Lombardi, Massimo ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c ARNAS   (Italy)

^d Villa Sofia Hospital   (Italy)

^e Centro Talassemia Ospedali Civili Riuniti   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g UNIVERSITY OF PISA   (Italy)

Author keywords

Blood oxygenation; Magnetic resonance; Myocardial fibrosis; T2*; Thalassemia

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; CHILD; COMPUTER MODEL; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TENSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AGED; CHILD; CONTRAST MEDIA; FEMALE; FIBROSIS; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; OXYGEN; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THALASSEMIA;

EID: 65249183906     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21704     Document Type: Article

References (37)

1. Weatherall DJ, Clegg JB. Thalassemia-a global public health problem. Nat Med 1996;2:847-849.
2. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193.
3. Aldouri MA, Wonke B, Hoffbrand AV, et al. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol 1990;84:113-117.
4. Wacker P, Halperin DS, Balmer- Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993;103:1276-1278.
5. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in highrisk beta-thalassemia. Blood 2000;95:1229-1236.
6. Gossuin Y, Roch A, Muller RN, Gillis P. Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange. Magn Reson Med 2000;43:237-243.
7. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
8. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-520.
9. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18:33-39.
10. Pepe A, Positano V, Santarelli F, et al. Multislice multiecho T2× cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006;23:662-668.
11. Pepe A, Lombardi M, Positano V, et al. Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*. Eur J Haematol 2006;76:183-192.
12. Positano V, Pepe A, Santarelli MF, et al. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed 2007;20:578-590.
13. St Pierre TG. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet 2003;361:182; author reply 183-184.
14. Macdonald RA, Mallory GK. Hemochromatosis and hemosiderosis. Studyof211 autopsied cases. Arch Intern Med 1960;105:686-700.
15. Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med 1971;51:209-221.
16. Olson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987;10:1239-1243.
17. Olson LJ, Edwards WD, Holmes DR Jr, Miller FA Jr, Nordstrom LA, Baldus WP. Endomyocardial biopsy in hemochromatosis: clinico- pathologic correlates in six cases. J Am Coll Cardiol 1989;13:116- 120.
18. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-59.
19. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260- 2264.
20. Bauer WR, Nadler W, Bock M, et al. Theoryofthe BOLD effect in the capillary region: an analytical approach for the determination ofT2 in the capillary network of myocardium. Magn Reson Med 1999; 41:51-62.
21. Wacker CM, Bock M, Hartlep AW, et al. Changes in myocardial oxygenation and perfusion under pharmacological stress with di- pyridamole: assessment using T*2 and T1 measurements. Magn Reson Med 1999;41:686-695.
22. Pennell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005;1054:373-378.
23. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myo- cardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiologyofthe American Heart Association. Circulation 2002;105:539-542.
24. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357: 21-28.
25. Positano V, Pingitore A, Giorgetti A, et al. A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7:487- 494.
26. Constantinides CD, Atalar E, McVeigh ER. Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med 1997;38:852-857.
27. Hobbhahn J, Conzen PF, Goetz A, et al. Myocardial surface PO2-an indicator of myocardial tissue oxygenation? Cardiovasc Res 1989;23:529-540.
28. Jubran A. Pulse oximetry. Crit Care 1999;3:11-17.
29. Pruitt WC, Jacobs M. Interpreting arterial blood gases: easy as ABC. Nursing 2004;34:50-53.
30. Cogliandro T, Derchi G, Mancuso L, et al. Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med (Hagerstown) 2008;9:515-525.
31. Gillis P, Roch A, Brooks RA. Corrected equations for susceptibility induced T2-shortening. J Magn Reson 1999;137:402-407.
32. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005;75:241-247.
33. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. Magma 1998;6:7-12.
34. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
35. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
36. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411-2416.
37. Pennell D. Myocardial salvage: retrospection, resolution, and radio waves. Circulation 2006;113:1821-1823.